IM Cannabis Posts Positive Cash Flow as Germany Revenue Surges

Event summary

IM Cannabis reported C$54.7M in revenue for 2025, with Germany operations driving a 134% year-over-year surge to C$36.3M.
The company achieved positive operating cash flow of C$4.7M, reversing a negative C$1.08M from 2024.
Gross profit increased by 15% to C$9.7M, supported by cost efficiencies and higher-margin German sales.
IM Cannabis raised C$5.1M through a private placement and extended convertible debentures, boosting cash reserves to C$3.3M.

The big picture

IM Cannabis's turnaround to positive operating cash flow highlights the strategic importance of its German operations, which now account for two-thirds of total revenue. The company's move into defense technology through Black Axe Technologies signals a broader diversification play amid regulatory and geopolitical risks in its core medical cannabis markets.

What we're watching

Geographic Expansion: How IM Cannabis will leverage Germany's medical cannabis legalization to sustain its revenue growth trajectory.
Diversification Strategy: Whether the proposed acquisition of Black Axe Technologies can successfully position IMC in the defense and homeland security sectors.
Operational Efficiency: The pace at which IM Cannabis can maintain its positive cash flow amid ongoing challenges in Israel.